Abstract:Generating and analyzing overlapping peptides through multienzymatic digestion is an efficient procedure for de novo protein using from bottom-up mass spectrometry (MS). Despite improved instrumentation and software, de novo MS data analysis remains challenging. In recent years, deep learning models have represented a performance breakthrough. Incorporating that technology into de novo protein sequencing workflows require machine-learning models capable of handling highly diverse MS data. In this study, we analyzed the requirements for assembling such generalizable deep learning models by systemcally varying the composition and size of the training set. We assessed the generated models' performances using two test sets composed of peptides originating from the multienzyme digestion of samples from various species. The peptide recall values on the test sets showed that the deep learning models generated from a collection of highly N- and C-termini diverse peptides generalized 76% more over the termini-restricted ones. Moreover, expanding the training set's size by adding peptides from the multienzymatic digestion with five proteases of several species samples led to a 2–3 fold generalizability gain. Furthermore, we tested the applicability of these multienzyme deep learning (MEM) models by fully de novo sequencing the heavy and light monomeric chains of five commercial antibodies (mAbs). MEMs extracted over 10000 matching and overlapped peptides across six different proteases mAb samples, achieving a 100% sequence coverage for 8 of the ten polypeptide chains. We foretell that the MEMs' proven improvements to de novo analysis will positively impact several applications, such as analyzing samples of high complexity, unknown nature, or the peptidomics field. In recent years, the application of deep learning represented a breakthrough in the mass spectrometry (MS) field by improving the assignment of the correct sequence of amino acids from observable MS spectra without prior knowledge, also known as de novo MS-based peptide sequencing. However, like other modern neural networks, models do not generalize well enough as they perform poorly on highly varied N- and C-termini peptide test sets. To mitigate this generalizability problem, we conducted a systematic investigation to uncover the requirements for building generalized models and boosting the performance on the MS-based de novo peptide sequencing task. Several experiments confirmed that the training set's peptide diversity directly impacts the resulting model's generalizability. Data showed that the best models were the multienzyme models (MEMs), i.e., models trained from a compendium of highly diverse peptides, such as the one generated from digesting a broad of species samples with a group of proteases. The applicability of these MEMs was later established by fully de novo sequencing 8 of the ten polypeptide chains of five commercial antibodies and extracting over 10000 proving peptides.

Accurate prediction of antibody deamidations by combining high-throughput automated peptide mapping and protein language model-based deep learning

The Accurate Prediction of Antibody Deamidations by Combining High-Throughput Automated Peptide Mapping and Protein Language Model-Based Deep Learning

Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based in silico approaches

Ab-Amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model

AB-Amy: machine learning aided Amyloidogenic risk prediction of therapeutic antibody light chains

PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning

Accurate Prediction of Antibody Function and Structure Using Bio-Inspired Antibody Language Model

Learning the Language of Antibody Hypervariability

Comprehensive evaluation of peptide de novo sequencing tools for monoclonal antibody assembly

DeepSP: Deep Learning-Based Spatial Properties to Predict Monoclonal Antibody Stability

AttABseq: an Attention-Based Deep Learning Prediction Method for Antigen-Antibody Binding Affinity Changes Based on Protein Sequences.

Protein language models enable prediction of polyreactivity of monospecific, bispecific, and heavy-chain-only antibodies

AMPDeep: hemolytic activity prediction of antimicrobial peptides using transfer learning

iAmideV-Deep: Valine Amidation Site Prediction in Proteins Using Deep Learning and Pseudo Amino Acid Compositions

Sequence-based deep learning antibody design for in silico antibody affinity maturation

UniproLcad: Accurate Identification of Antimicrobial Peptide by Fusing Multiple Pre-Trained Protein Language Models

Deepmal: Accurate Prediction Of Protein Malonylation Sites By Deep Neural Networks

Multienzyme deep learning models improve peptide de novo sequencing by mass spectrometry proteomics

Prediction of Aggregation Prone Regions in Proteins Using Deep Neural Networks and Their Suppression by Computational Design